Shares in Hologic (NSDQ:HOLX) fell today after the medical device maker missed sales expectations on Wall Street with its 3rd quarter earnings results. The Marlborough, Mass.-based company posted profits of $59.5 million, or 21¢ per share, on sales of $806.1 million for the 3 months ended June 25, seeing its bottom line shrink 29.8% while sales […]
MassDevice Earnings Roundup
Teleflex shares rise on Q2 beat and raise
Shares in Teleflex (NYSE:TFX) rose today after the medical device maker topped expectations on Wall Street with its 2nd quarter earnings results, providing lifted guidance for the rest of its fiscal year. The Wayne, Penn.-based company posted profits of $78 million, or $1.67 per share, on sales of $528.6 million for the 3 months ended June […]
BD shares fall on Q3 sales miss
Shares in Becton Dickinson & Co. (NYSE:BDX) have fallen today after the medical device maker narrowly topped earnings per share expectations but missed sales consensus on Wall Street with its 3rd quarter results. The Franklin Lakes, N.J.-based company posted losses of $165 million, or 75¢ per share, on sales of $3 billion for the 3 months […]
Teva lowers outlook after Q2 EPS misses estimates
(Reuters) – Israeli drugs group Teva Pharmaceuticals (NYSE:TEVA) reported a steeper than expected drop in second-quarter earnings on Thursday, due to weaker prices in the United States, and cut its interim dividend by 75 percent. Along with a substantial reduction in its 2017 outlook, shares in the world’s largest generics drugmaker tumbled 16.5 percent in Tel Aviv […]
Halyard Health rises on Q2 EPS beat
Shares in Halyard Health (NYSE:HYH) rose today after the medical device maker beat expectations on Wall Street with its 2nd quarter earnings. The Alpharetta, Ga.-based company posted profits of $17.1 million, or 36¢ per share, on sales of $399.2 million for the 3 months ended June 30, for massive bottom-line growth of 163.1% while sales shrank […]
Pacira misses on Q2 sales, earnings
Shares in Pacira Pharmaceuticals (NSDQ:PCRX) fell slightly today after the pharmaceutical company missed expectations on Wall Street with its second quarter results. The Parsippany, N.J.-based company posted a net loss of -$19.7 million, or -49¢ per share, on sales of $70.9 million for the 3 months ended June 30, for bottom-line loss of -148% on sales growth […]
K2M slides on Q2 sales miss
Shares in K2M (NSDQ:KTWO) fell today after the medical device maker met loss per share expectations but missed sales consensus on Wall Street with its 2nd quarter earnings results. The Leesburg, Va.-based company posted losses of $9.1 million, or 21¢ per share, on sales of $65.7 million for the 3 months ended June 30, seeing losses […]
Aerie Pharmaceuticals misses Q2 EPS by a penny
Shares in Aerie Pharmaceuticals (NSDQ:AERI) held steady today after the pharmaceutical company missed EPS estimates on Wall Street with its second quarter results. The Irvine, Calif.-based company posted a net loss of -$28.4 million, or -82¢ per share, with its bottom line down -22.5% compared with the same period last year. Get the full story at our […]
ResMed shares drop on Q4, FY2017 earnings release
Shares in ResMed (NYSE:RMD) fell today after the respiratory medical device maker posted 4th quarter and and fiscal year 2017 earnings that mostly came out on-top of Wall Street analyst’s expectations, but saw profits shrink nearly 3% compared to the previous year. The San Diego, Calif.-based company posted profits of $101.6 million, or 70¢ per share, […]
DexCom shares rise on Q2 beat, new CFO
Shares in Dexcom (NSDQ:DXCM) rose today after the diabetes-focused medical device maker topped expectations on Wall Street with its 2nd quarter earnings results and announced a new chief financial officer. The San Diego, Calif.-based company posted profits of $2.9 million, or 3¢ per share, on sales of $170.6 million for the 3 months ended June 30, […]
Cardinal Health shares drop on Q4, FY2017 earnings release
Shares in Cardinal Health (NYSE:CAH) fell today after the medical device maker posted a 17.7% drop in profits in its 4th quarter and 9.6% drop for its fiscal year 2017 earnings results, despite topping expectations on Wall Street. The Dublin, Ohio-based company posted profits of $274 million, or 86¢ per share, on sales of $33 billion […]